Trelegy ellipta 100-62.5-25 60S
Ended Awarded
- Contract number
- SPE2DB25FQRLB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,774
Award facts
- Contract value 100% obligated
- $5,773.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $5,773.90 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count) on August 5, 2025, with completion scheduled for August 6, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitively awarded transaction under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's distribution facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical distributor serving federal medical procurement needs.
This delivery order falls under AmerisourceBergen's comprehensive $999,999,999.00 indefinite delivery contract (SPE2DX) with DLA Troop Support Medical, which extends through December 2026 and serves as a global pharmaceutical support vehicle for military healthcare systems. Trelegy Ellipta is a combination respiratory medication used for chronic obstructive pulmonary disease management, representing the type of specialty pharmaceutical product that AmerisourceBergen supplies across its extensive federal contract portfolio with the Defense Health Agency and other government healthcare systems. The award demonstrates the company's ongoing capability to fulfill federal medical supply requirements through open competition and its established role as a critical pharmaceutical vendor for military and veteran healthcare procurement.
Quick answers
Who was awarded contract SPE2DB25FQRLB?
SPE2DB25FQRLB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 5, 2025.
How much is contract SPE2DB25FQRLB worth?
The government has obligated $5,774 on SPE2DB25FQRLB.
Is contract SPE2DB25FQRLB an order under another contract?
Yes. SPE2DB25FQRLB is a delivery order under SPE2DB25D2207, an indefinite delivery contract.
Was contract SPE2DB25FQRLB competed?
The extent of competition for SPE2DB25FQRLB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award